The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Sun., Jun. 20, 1:44 AM

Slide #2. NeoGenomics, Inc. Inivata Ltd

Acquirer: NeoGenomics, Inc. (NASDAQ:NEO)
Acquiree: Inivata Ltd
Details: NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today that it has completed its acquisition of Inivata Ltd, a global, commercial stage liquid biopsy platform company headquartered in Cambridge, England.

NeoGenomics operate a network of cancer-focused testing laboratories in the United States as well as laboratories in Switzerland and Singapore. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope.

NEO SEC Filing Email Alerts Service


Open the NEO Page at The Online Investor »

Company Name: 
NeoGenomics Inc
Website: 
www.neogenomics.com
Sector: 
Diagnostics
Number of ETFs Holding NEO: 
46
Total Market Value Held by ETFs: 
$1.12B
Total Market Capitalization: 
$5.04B
% of Market Cap. Held by ETFs: 
22.30%
 

Open the NEO Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (3.68 out of 4)
65th percentile
(ranked higher than approx. 65% of all stocks covered)

Analysts' Target Price:
NEO Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.